Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujimasa Tada

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Internal Medicine (Tokyo, Japan)|March 30, 2025
Relationship between daily physical activity and muscle cramping in elderly liver cirrhosis patients-A multicenter studyAtsushi Hiraoka, Tadashi Namisaki, Masato Nakai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 15, 2026
Development of a Risk-Estimation Model for Identifying Patients at Risk of Early Skeletal Muscle Mass Loss in Chronic Liver DiseaseAtsushi Hiraoka, Hideko Ohama, Fujimasa Tada, et al.
Journal of Gastroenterology and Hepatology|February 25, 2024
mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological responseToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Internal Medicine (Tokyo, Japan)|March 10, 2015
Drug-induced liver injury with serious multiform exudative erythema following the use of an over-the-counter medication containing ibuprofenTakao Watanabe, Masanori Abe, Fujimasa Tada, et al.
Internal Medicine (Tokyo, Japan)|October 18, 2011
Ulcerative colitis complicated with primary biliary cirrhosisFujimasa Tada, Masanori Abe, Hiroaki Nunoi, et al.
Journal of Gastroenterology|January 8, 2017
Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH)Hiroki Utsunomiya, Yasunori Yamamoto, Eiji Takeshita, et al.
Internal Medicine (Tokyo, Japan)|June 17, 2014
An HBV-HIV co-infected patient treated with tenofovir-based therapy who achieved HBs antigen/antibody seroconversionTakao Watanabe, Yoshio Tokumoto, Masashi Hirooka, et al.
Hepatology International|July 24, 2015
B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver diseaseTeruki Miyake, Masanori Abe, Yoshio Tokumoto, et al.
International Journal of Oncology|September 14, 2012
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinomaFujimasa Tada, Masanori Abe, Masashi Hirooka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 8, 2023
Clinical role of radiofrequency ablation for early-stage hepatocellular carcinoma in an advanced aging societyHironori Ochi, Atsushi Hiraoka, Takaaki Tanaka, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Internal Medicine (Tokyo, Japan)|March 30, 2025
Relationship between daily physical activity and muscle cramping in elderly liver cirrhosis patients-A multicenter studyAtsushi Hiraoka, Tadashi Namisaki, Masato Nakai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 15, 2026
Development of a Risk-Estimation Model for Identifying Patients at Risk of Early Skeletal Muscle Mass Loss in Chronic Liver DiseaseAtsushi Hiraoka, Hideko Ohama, Fujimasa Tada, et al.
Journal of Gastroenterology and Hepatology|February 25, 2024
mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological responseToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Internal Medicine (Tokyo, Japan)|March 10, 2015
Drug-induced liver injury with serious multiform exudative erythema following the use of an over-the-counter medication containing ibuprofenTakao Watanabe, Masanori Abe, Fujimasa Tada, et al.
Internal Medicine (Tokyo, Japan)|October 18, 2011
Ulcerative colitis complicated with primary biliary cirrhosisFujimasa Tada, Masanori Abe, Hiroaki Nunoi, et al.
Journal of Gastroenterology|January 8, 2017
Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH)Hiroki Utsunomiya, Yasunori Yamamoto, Eiji Takeshita, et al.
Internal Medicine (Tokyo, Japan)|June 17, 2014
An HBV-HIV co-infected patient treated with tenofovir-based therapy who achieved HBs antigen/antibody seroconversionTakao Watanabe, Yoshio Tokumoto, Masashi Hirooka, et al.
Hepatology International|July 24, 2015
B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver diseaseTeruki Miyake, Masanori Abe, Yoshio Tokumoto, et al.
International Journal of Oncology|September 14, 2012
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinomaFujimasa Tada, Masanori Abe, Masashi Hirooka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 8, 2023
Clinical role of radiofrequency ablation for early-stage hepatocellular carcinoma in an advanced aging societyHironori Ochi, Atsushi Hiraoka, Takaaki Tanaka, et al.
Pageof 12